New York State Common Retirement Fund’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
DIM
PFSRSONJ
DT
BCM
KCM
CUAMC
SCM
SS
New York State Common Retirement Fund's BDTX Position: Q2 2026 in Review
New York State Common Retirement Fund opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 30,300 shares worth $56.1K. The stake represents ﹤0.01% of the portfolio and ranks #2958 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in BDTX as recently as Q1 2025.
New York State Common Retirement Fund first reported a position in BDTX in Q2 2020 and has held it in 14 quarters since. The position peaked at $529K in Q4 2020. 11 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.
- New York State Common Retirement Fund held 30,300 shares of Black Diamond Therapeutics worth $56.1K as of Q2 2026.
- Black Diamond Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
- Black Diamond Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2958 holding.
- New York State Common Retirement Fund first reported a position in Black Diamond Therapeutics in Q2 2020 and has held it in 14 quarters since.
- New York State Common Retirement Fund's Black Diamond Therapeutics position peaked at $529K in Q4 2020.
- 11 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.